Characteristics and survival of patients with non-small cell lung cancer treated with immune-checkpoint inhibitors in the real-world: experiences from Bergen, Norway

Authors

  • Fabian Gärtner Department of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway
  • Jörg Aßmus Centre for Clinical Research, Haukeland University Hospital, Bergen, Norway
  • Øystein Fløtten Department of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway; Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway
  • Maria Paula Ramnefjell Department of Pathology, Haukeland University Hospital, Bergen, Norway; Department of Clinical Medicine, Faculty of Medicine, University of Bergen, Bergen, Norway
  • Marianne Aanerud Department of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway; Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway

DOI:

https://doi.org/10.1080/0284186X.2022.2068969

Abstract

No Abstract available

Downloads

Download data is not yet available.

Downloads

Additional Files

Published

2022-07-03

How to Cite

Gärtner, F., Aßmus, J., Fløtten, Øystein, Paula Ramnefjell, M., & Aanerud, M. (2022). Characteristics and survival of patients with non-small cell lung cancer treated with immune-checkpoint inhibitors in the real-world: experiences from Bergen, Norway. Acta Oncologica, 61(7), 814–818. https://doi.org/10.1080/0284186X.2022.2068969

Issue

Vol. 61 No. 7 (2022): Acta Oncologica

Section

Articles